Black Diamond Therapeutics, Inc.
Status: Publicly traded
Direct answer
Black Diamond Therapeutics, Inc. is publicly traded on NASDAQ under the ticker BDTX.
Black Diamond Therapeutics, Inc. is a biotechnology enterprise dedicated to discovering, advancing, and bringing to market therapeutic agents specifically designed for patients with genetically characterized tumors. A core part of its pipeline is BDTX-189, an irreversible small molecule inhibitor. This compound is engineered to neutralize oncogenic proteins driven by non-canonical epidermal growth factor receptor...
Can you invest in Black Diamond Therapeutics, Inc.?
Yes. Black Diamond Therapeutics, Inc. trades publicly on NASDAQ as BDTX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Black Diamond Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.